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 Introduction: A disease of the reproductive system defined by the failure to achieve a clinical 
pregnancy after12 months or more of regular unprotected sexual intercourse. The demand for 
overcoming infertility is increasing year by year. Hence there is a quantum jump in the 
technology used in the diagnosis and therapy of infertility. Aim/ Objective: To observe the 
rationality among the prescriptions with principle aim to study the efficacy, tolerability, safety 
and cost-effectiveness of the drugs used in infertility cases and  to evaluate the prescribing 
pattern and criteria for selection of drugs for infertility. Methodology: A retrospective, 
observational study was conducted in the department of Obstetrics and Gynecology at Owaisi 
Hospital and Research Centre, Hyderabad, India. The duration of the study was 15 month 
period from September 2015 to Dec 2016 on 300 consenting female infertility patients. 
Results: In our study 43% of patients belonged to age group 26-30. 45% were newly 
diagnosed patients,65.3 % of patients had primary infertility and whereas 34.6% had 
secondary infertility. Menstrual irregularity were the most common cause of infertility (36%). 
The patients were treated with drug alone depending on their age and cause of infertility. 
Clomiphene Citrate (12.76%) was the most common drug prescribed for ovulation 
induction.55.3 % of patients conceived during our study, women who failed to achieve 
pregnancy needed Assisted Reproductive Technology. The PDD and DDD was calculated to 
achieve rationality of prescriptions. Conclusion: Infertility is a critical component of 
reproductive health which is a global public health challenge. The use of 
pharmacoepidemological data can help in designing, delivering and evaluating many 
interventions to improve the use of fertility drugs and outcome of patients as Infertility is a 
global health issue. 
Please cite this article in press as Shaheda Siddiqui et al. A Retrospective Study on Prescribing Pattern of Drugs in Female 
Infertility at A Tertiary Care Centre in South India. Indo American Journal of Pharmaceutical Research.2017:7(03). 
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INTRODUCTION 
The ability to reproduce and to perpetuate the species is one of the most remarkable features of the living organisms. Fertility 
and infertility have been a major concern to mankind since time immemorial. Infertility is seldom, if ever, a physically debilitating 
disease. It may, however, severely affect the couple's psychological harmony, married life and also the healthcare services along with 
the social environment [1].The clinical definition of infertility used by the World Health Organization (WHO) is “a disease of the 
reproductive system defined by the failure to achieve a clinical pregnancy after12 months or more of regular unprotected sexual 
intercourse”[2]. Infertility can be subdivided into primary infertility, that is, no prior pregnancies, and secondary infertility, referring 
to infertility following at least one prior conception [3].Globally, most infertile couples suffer from primary infertility [4]. The demand 
for overcoming infertility is increasing year by year. Hence there is a quantum jump in the technology used in the diagnosis and 
therapy of infertility. There is also a tremendous escalation of cost in management of infertility cases. This fact is an important cause 
of concern in the economic development of a country. Therefore the following study is an attempt made to see the rationality among 
the prescriptions with principle aim to study the efficacy, tolerability, safety and cost-effectiveness of the drugs used in infertility 
cases and to evaluate the prescribing pattern and criteria for selection of drugs for infertility. 
 
MATERIALS AND METHODS 
This Retrospective, observational study was conducted in the department of Obstetrics and Gynecology at Owaisi Hospital 
and Research Centre,Hyderabad, India. The duration of the study was 15 month period from September 2015 to Dec 2016 on 300 
consenting female infertility patients. No Institutional ethics committee approval was required as it is a retrospective observational 
study and written informed consent was obtained from each patient before enrolment. Demographic details, necessary clinical data, 
and medication details were collected in a specially designed proforma. Data on utilization of different classes as well as individual 
drugs were subjected to descriptive analysis. 
 
Inclusion criteria: 
Female patients presenting with infertility in the outpatient department of the hospital within the reproductive age group (20-
40 years) consenting for the study. 
 
Exclusion criteria: 
1. Cancer patients, at terminal stage. 
2. Females before and after reproductive age. 
 
The data analysis was done as follows  
1. Assessment of prescription pattern as per WHO drug use indicator.  
2. The prescribed drugs were classified according to the Anatomical Therapeutic classification (ATC)-Defined Daily Dose (DDD) 
Classification.[5] 
3. The prescribed Daily Dose (PDD) was calculated by taking the average of the daily doses of psychotropic drugs as PDD. The 
PDD to DDD Ratio was then calculated.[5] 
 
RESULTS 
 
Table 1 Based on Age. 
 
Age No. of Patients (%)  
20-25 122(40.6) 
26-30 129(43) 
31-35 33(11) 
36-40 16(5.3) 
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Figure 1: Based on Age. 
 
Table 2 Grade of Infertility. 
 
Grade of Infertility No. of Patients (%) 
Primary 196(65.3) 
Secondary 104(34.6) 
 
 
 
Fig 2: Grade of Infertility. 
 
Table 3 Based on Associated Co- morbid Conditions/ Cause of Infertility. 
 
Cause of Infertility No. of Patients (%) 
Polycystic Ovaries 31(10.3) 
Polycystic Ovarian Syndrome 47(15.66) 
Subclinical Hypothyroidsm 16(5.3) 
Endometriosis 14(4.6) 
Age related Ovulatory dysfunction 12(4) 
Hostile Mucus 7(2.3) 
Increase level of Prolactin 24(8) 
Menstrual irregularities 108(36) 
Genital Kochs 14(4.6) 
Unexplained 27(9) 
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Fig 3: Based on Associated Co- morbid Conditions/ Cause of Infertility. 
 
Table 4. Distribution of Drugs prescribed in patients (N=300). 
 
Name of the Drugs % of Prescribed drugs 
Siphene (Clomiphene Citrate) 12.76 
Duphaston (Dydrogesterone) 12.56 
Progynova(Estradiol Valerate) 16.27 
Regesterone (Norethindrone acetate) 8.70 
HCG (Human Chorionic Gonadotropin) 1.18 
Positive(Pioglitazone) 4.49 
Glyciphage(Metformin) 2.03 
Tamoxifen(Tamoxifen Citrate) 3.89 
Geocyst (Metformin+Myoinositol) 0.92 
Cabergoline(Cabergoline) 0.35 
Folvite(Folic Acid) 86.9 
Oflox(Ofloxacin) 5.7 
Clindamycin(Clindamycin) 0.46 
Norflox(Norfloxacin) 0.79 
Anti Tubercular 0.18 
Taxim (Cefixime) 0.31 
Azwin(Azithromycin) 0.26 
Monocef (Cefpodoxime) 0.56 
Metrogyl IV(Metronidazole) 0.05 
Augpen (Amoxycillin+ Potassium Clavunate) 0.27 
Diclomol(Diclofenac+ Paracetamol) 4.24 
Chymoral Forte(Chymotrypsin+Trypsin) 0.39 
Voveran(Diclofenac Sodium) 1.91 
Pyridoxine 7.42 
Eltroxin(Levothyroxine) 0.21 
Ebexid 0.13 
Hydrocort(Hydrocortisone) 0.10 
Zofer(Ondansetron) 0.36 
Rabion(Rabeprazole) 4.49 
Pantop(Pantoprazole) 1.69 
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Figure 4. Distribution of Drugs prescribed in patients (N=300). 
 
Table 5: Distribution of Patients according to outcome of therapy. 
 
Outcome of Therapy No. of Patients (%) 
Conceived 166(55.3) 
Not conceived 73(24.3) 
Missed Abortions 12(4) 
Ectopic Pregnancy 4(1.33) 
Left Against Medical Advice 45(15) 
 
 
 
Figure 5: Distribution of Patients according to outcome of therapy. 
 
Table 6: WHO Drug Used Indicators: 
 
Prescribing Indicators Data 
Availability of copy of Essential Drug list & Hospital Formulary Yes 
Total no. of Drugs in 300 Patients during the study period 7569 
Average no. of drugs per patient during the study period 25 
Total no. of Ovulatory Drugs in 300 Patients during the study period 5328 
 Percentage of Ovulatory drugs per patient during the study period 70.3% 
Percentage of Other drugs per patient during the study period 21% 
Percentage of Drugs prescribed by generic Name  58% 
Percentage of Prescriptions with an antibiotic prescribed 8.62% 
Percentage of Prescriptions with an Injection Prescribed 1.34% 
Percentage of Drugs prescribed from Essential Drug List / Hospital Formulary 80% 
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Table 7:  PDD Values & PDD/DDD Ratios of Ovulation Drugs prescribed in a sample of 300 Patients attending Infertility 
Unit. 
 
DRUG ATC CODE ROA DDD (mg) PDD (mg) PDD/DDD 
Siphene G03GB02 Oral 50 161 3.22 
Duphaston G03DB01 Oral 10 31.7 3.17 
Progynova G03DC02 Oral 2 8.2 4.10 
Regesterone G03DC02 Oral 5 10.983 2.19 
Cabergoline G02CB03 Oral 0.5 0.045 0.09 
Glyciphage A10BA02 Oral 250 128.33 0.513 
Positive A10BG03 Oral 15 17 1.13 
Tamoxifen L02BA02 Oral 20 19.66 0.98 
Geocyst A10BA02 Oral 500 116 0.23 
HCG-5000IU G03GA01 IM 500 150 0.3 
Folvite B03BB01 Oral 5 9.06 1.81 
 
 
 
 
 
 
 
Table 8: DDD Values of Ovulation Drugs prescribed in a sample of 300 Patients attending Infertility Unit. 
 
Drugs No. of Prescribed Doses Strength  DDD  WHO-DDD DDD/300 Patients PDD 
mg mg gm mg gm 
Siphene 966 50 50 0.05 0.166 0.0016 161 
Duphaston 951 10 10 0.01 0.03 0.000033 31.7 
Progynova 1232 2 2 0.002 0.007 0.0000066 8.21 
Regesterone 659 5 5 0.005 0.016 0.000016 10.98 
Cabergoline 27 0.5 0.5 0.0005 0.0016 0.0000016 0.045 
Glyciphage 154 250 250 0.25 0.83 0.000833 128 
Positive 340 15 15 0.015 0.05 0.00005 17 
Tamoxifen 295 20 20 0.02 0.06 0.00006 19.66 
Geocyst 70 500 500 0.5 1.66 0.001666 116.6 
HCG-5000IU 90 500 500 0.5 1.66 0.0016 150 
Folvite  544 5 5 0.005 0.0166 0.000016 9.06 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PDD= Quantity of drug dispensed x Strength of drug 
                                             No. of Patients  
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DISCUSSION 
 In our study of 300 patients, 43% belonged to age group of 26-30 as shown in Table and Figure 1.  45% were newly 
diagnosed patients. 65.3% had primary infertility as depicted in Table and Figure 2. Causes of infertility are shown in Table and 
Figure 3 where menstrual irregularities (36%) were noticed as a common cause for infertility. Sub clinical hypothyroidism was 
observed in 5.3% of patients. Hashimoto’s thyroiditis is the most common endocrinopathy in premenopausal women, and is associated 
with various gynecological problems, including recurrent miscarriages and unexplained infertility.Strict thyroid hormone 
supplementation egimen was followed to achieve desirable TSH levels.[6] The distribution of drugs prescribed in 300 patients during 
study period are depicted in Table and Figure 4 among which Clomiphene Citrate (12.76%)  was commonly prescribed as ovulation 
induction drug as it has antiestrogenic action,which induces gonadotropin secretion by blocking estrogenic action,which induces 
gonadotropin secretion by blocking estrogenic feedback inhibition of pituitary[7]along with supportive therapy with Progynova 
(16.27%) as a study conducted by Gleicher et al have demonstrated the combined effet of estradiol and progesterone substitution of 
the luteal phase of ovulation induction cycles increases the overall pregnancy rate,especially in women beow 38 years of age and 
nulliparous women[8],progesterone supplementations were advised in patients as it is essential for luteal phase support in patients with 
luteal phase defect.[9]  and Folic Acid supplementation (86.9%) as it is a well-established fact that folic acid supplementation reduces 
neural tube defects of fetus.[9] In patients with PCOS showing Clomiphene resistance,metformin was prescribed followed by regular 
menstrual cycles, reduction in hyperandrogenism and improvement in raes of ovulation and conception.[10] 
 The outcome of therapy is depicted in Table and Figure 5, Conceived were 166(55.3%) patients.  As illustrated in Table 6, 
Total drugs prescribed in 300 patients during the study period of 15 months were 7569 among which ovulatory drugs were found to be 
5328. Percentage of ovulatory drugs per patient contributed to 70.3% whereas other drugs advised were 21%. Average no.of drugs per 
patient were 25; drugs prescribed with generics were 58%. Antibiotics prescribed were 8.62%, Drugs from EDL and Hospital 
Formulary were 80%. 
 PDD-Prescribed Daily Dose of drugs and DDD- Defined Daily Dose was calculated as depicted in Table 7. The ratio of 
PDD/DDD was calculated for each drug and the prescribing pattern of drugs was found to be rational as well explained in Table 8. 
In today’s modern world, medical science has various new and advanced technologies like ART (Assisted Reproductive Technology) 
and IVF (In Vitro Fertilization) to help those numerous childless couples, who are seeking treatment of infertility, some tests should 
be initiated to provide the outcome prognosis for assisted reproductive technology [6]In the present study, the pattern of drugs used to 
treat infertility has been studied along with the evaluation of outcome of therapy in 300 patients after fulfilling the inclusion criteria. 
 
LIMITATIONS OF THE STUDY: 
1. The sample size of the patients was small to calculate prescribing pattern of drugs in infertility cases. 
2. Follow up duration is short. 
3. Further studies in various hospitals are required which will broaden the knowledge about the management of infertility. 
 
CONCLUSION 
 Women with reproductive dysfunction who fail to achieve pregnancy need ART/IVF. The use of pharmacoepidemological 
data can help in designing, delivering and evaluating many interventions to improve the use of fertility drugs and outcome of patients 
as Infertility is a global health issue.  
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